Fate Therapeutics (FATE) Interest Expenses (2013 - 2019)
Fate Therapeutics (FATE) reported Interest Expenses of $600000.0 for Q4 2019, up 39.53% on a YoY basis from $430000.0 in Q4 2018, and up 50.0% quarter-over-quarter from $400000.0 in Q3 2019.
Fate Therapeutics (FATE) Interest Expenses (2013 - 2019) Analysis & Trends
Fate Therapeutics has reported Interest Expenses for 7 years, with the latest figure at $600000.0 in Q4 2019.
- For the quarter ending Q4 2019, Interest Expenses rose 39.53% year-over-year to $600000.0; the trailing twelve-month figure through Sep 2020 stood at $600000.0 (down 63.3% YoY), and the FY2019 full-year result was $1.8 million, up 6.13% from the prior year.
- Interest Expenses for Q4 2019 stood at $600000.0, up from $400000.0 in the prior quarter.
- The five-year high for Interest Expenses was $600000.0 in Q3 2015, with the low at $212000.0 in Q2 2017.
- Historically, Interest Expenses has averaged $433800.0 across 5 years, with a median of $418500.0 in 2017.
- Annual changes were most pronounced in 2015 — Interest Expenses surged 1910.71% — and 2017, when it slumped 51.26%.
- Fate Therapeutics' Interest Expenses stood at $537000.0 in 2015, then tumbled by 38.73% to $329000.0 in 2016, then climbed by 25.23% to $412000.0 in 2017, then rose by 4.37% to $430000.0 in 2018, then jumped by 39.53% to $600000.0 in 2019.
- The last three Interest Expenses figures came in at $600000.0 (Q4 2019), $400000.0 (Q3 2019), and $400000.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 600,000.00 |
| Dec 31, 2019 | 600,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Mar 31, 2019 | 405,000.00 |
| Mar 31, 2019 | 405,000.00 |
| Dec 31, 2018 | 430,000.00 |
| Dec 31, 2018 | 430,000.00 |
| Sep 30, 2018 | 429,000.00 |
| Sep 30, 2018 | 429,000.00 |
| Jun 30, 2018 | 425,000.00 |
| Jun 30, 2018 | 425,000.00 |
| Mar 31, 2018 | 412,000.00 |
| Mar 31, 2018 | 412,000.00 |
| Dec 31, 2017 | 412,000.00 |
| Dec 31, 2017 | 412,000.00 |
| Sep 30, 2017 | 378,000.00 |
| Sep 30, 2017 | 378,000.00 |